First Turn Management’s Mirum Pharmaceuticals MIRM Stock Holding History

First Turn Management's MIRM Position: Q2 2026 in Review

First Turn Management reduced its Mirum Pharmaceuticals (MIRM) stake by 46% in Q2 2026, selling an estimated $18.3M and leaving 218,051 shares worth $25.5M. The position accounts for 2.73% of the portfolio, ranked #18.

First Turn Management first reported a position in MIRM in Q4 2023 and has held it in 11 quarters since. The position peaked at $41.8M in Q3 2025. 328 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

• First Turn Management held 218,051 shares of Mirum Pharmaceuticals worth $25.5M as of Q2 2026.
• First Turn Management sold 182,413 Mirum Pharmaceuticals shares in Q2 2026, an estimated $18.3M.
• Mirum Pharmaceuticals made up 2.73% of First Turn Management's portfolio in Q2 2026, its #18 holding.
• First Turn Management first reported a position in Mirum Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
• First Turn Management's Mirum Pharmaceuticals position peaked at $41.8M in Q3 2025.
• 328 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on First Turn Management's 13F filing for Q2 2026, filed 14 Aug 2026.